EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

How to increase the effectiveness of medication therapy in patients with active thyroid eye disease

Olga G. Panteleeva, Fatima H. Batyrbekova, Svetlana V. Saakyan

Ophthalmology Reports · 31.03.2026 · 19 (1) · 31-39

DOI: 10.17816/ov678591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmology Reports, online erschienen am 31.03.2026. Verfasst von Olga G. Panteleeva und 2 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Thyroid eye disease is an independent progressive autoimmune eye condition involving the thyroid gland. Thyroid eye disease requires researches because of the high risk of visual impairment, and permanent vision loss develops with delayed treatment or therapy not based on activity and severity. The disease progresses to more severe forms in up to 15% of cases, leading to a decrease in visual function up to its complete loss. The article describes first combined medication therapy and assesses its effectiveness. AIM: The study aimed to assess the effectiveness of combined medication therapy, including glucocorticoid pulse therapy for active thyroid eye disease. METHODS: A total of 84 patients with active thyroid eye disease aged 26 to 75 years were treated and underwent comprehensive clinical ophthalmological examination and imagining before and after treatment. All patients received combined medication therapy, including high-dose glucocorticoid therapy, cyclophosphamide, and symptomatic and topical therapy. The mean follow-up was 86.2 ± 8.7 months. RESULTS: The treatment course effectiveness, including cyclophosphamide injections, was 94.6% with no clinically significant side effects. There were three cases of reactivation of thyroid eye disease caused by a recurrence of thyroid disease after 6 months CONCLUSION: Additional immunosuppressive agents and symptomatic therapy in the treatment strategy, along with high-dose glucocorticoids, increase the treatment effectiveness up to 96.4%, restore visual function, and provide sustained remission.

Zitieren

APA

Panteleeva, O. G., Batyrbekova, F. H., & Saakyan, S. V. (2026). How to increase the effectiveness of medication therapy in patients with active thyroid eye disease. Ophthalmology Reports, 19(1), 31-39. https://doi.org/10.17816/ov678591

Vancouver

Panteleeva OG, Batyrbekova FH, Saakyan SV. How to increase the effectiveness of medication therapy in patients with active thyroid eye disease. Ophthalmology Reports. 2026;19(1):31-39. doi:10.17816/ov678591

BibTeX
@article{Panteleeva2026,
  author = {Panteleeva, Olga G. and Batyrbekova, Fatima H. and Saakyan, Svetlana V.},
  title = {How to increase the effectiveness of medication therapy in patients with active thyroid eye disease},
  journal = {Ophthalmology Reports},
  year = {2026},
  volume = {19},
  number = {1},
  pages = {31--39},
  doi = {10.17816/ov678591}
}
Kostenlos starten →